278 related articles for article (PubMed ID: 20801557)
1. The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.
Xiao ZP; Ma TW; Fu WC; Peng XC; Zhang AH; Zhu HL
Eur J Med Chem; 2010 Nov; 45(11):5064-70. PubMed ID: 20801557
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.
Mao WJ; Lv PC; Shi L; Li HQ; Zhu HL
Bioorg Med Chem; 2009 Nov; 17(21):7531-6. PubMed ID: 19804978
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.
Xiao ZP; Peng ZY; Dong JJ; He J; Ouyang H; Feng YT; Lu CL; Lin WQ; Wang JX; Xiang YP; Zhu HL
Eur J Med Chem; 2013 May; 63():685-95. PubMed ID: 23567958
[TBL] [Abstract][Full Text] [Related]
4. Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors.
Li HQ; Xiao ZP; Yin-Luo ; Yan T; Lv PC; Zhu HL
Eur J Med Chem; 2009 May; 44(5):2246-51. PubMed ID: 18625539
[TBL] [Abstract][Full Text] [Related]
5. Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease.
Xiao ZP; Shi DH; Li HQ; Zhang LN; Xu C; Zhu HL
Bioorg Med Chem; 2007 Jun; 15(11):3703-10. PubMed ID: 17400458
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking, kinetics study, and structure-activity relationship analysis of quercetin and its analogous as Helicobacter pylori urease inhibitors.
Xiao ZP; Wang XD; Peng ZY; Huang S; Yang P; Li QS; Zhou LH; Hu XJ; Wu LJ; Zhou Y; Zhu HL
J Agric Food Chem; 2012 Oct; 60(42):10572-7. PubMed ID: 23067328
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease.
Cui YM; Dong XW; Chen W; Wang WJ; Li YG; Zhu HL
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):528-32. PubMed ID: 22809106
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, and molecular docking studies of 2,5-substituted-1,4-benzoquinone as novel urease inhibitors.
You ZL; Xian DM; Zhang M; Cheng XS; Li XF
Bioorg Med Chem; 2012 Aug; 20(16):4889-94. PubMed ID: 22824761
[TBL] [Abstract][Full Text] [Related]
9. Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils.
Ohta T; Shibata H; Kawamori T; Iimuro M; Sugimura T; Wakabayashi K
Biochem Biophys Res Commun; 2001 Jul; 285(3):728-33. PubMed ID: 11453654
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
Xiao ZP; Peng ZY; Dong JJ; Deng RC; Wang XD; Ouyang H; Yang P; He J; Wang YF; Zhu M; Peng XC; Peng WX; Zhu HL
Eur J Med Chem; 2013 Oct; 68():212-21. PubMed ID: 23974021
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of phosphoramide derivatives as urease inhibitors.
Domínguez MJ; Sanmartín C; Font M; Palop JA; San Francisco S; Urrutia O; Houdusse F; García-Mina J
J Agric Food Chem; 2008 May; 56(10):3721-31. PubMed ID: 18452297
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors.
Aslam MA; Mahmood SU; Shahid M; Saeed A; Iqbal J
Eur J Med Chem; 2011 Nov; 46(11):5473-9. PubMed ID: 21981981
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.
Xiao ZP; Shi WK; Wang PF; Wei W; Zeng XT; Zhang JR; Zhu N; Peng M; Peng B; Lin XY; Ouyang H; Peng XC; Wang GC; Zhu HL
Bioorg Med Chem; 2015 Aug; 23(15):4508-4513. PubMed ID: 26113187
[TBL] [Abstract][Full Text] [Related]
14. Biological evaluation and molecular docking of baicalin and scutellarin as Helicobacter pylori urease inhibitors.
Yu XD; Zheng RB; Xie JH; Su JY; Huang XQ; Wang YH; Zheng YF; Mo ZZ; Wu XL; Wu DW; Liang YE; Zeng HF; Su ZR; Huang P
J Ethnopharmacol; 2015 Mar; 162():69-78. PubMed ID: 25557028
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and molecular docking study of piperazine derivatives as potent urease inhibitors.
Taha M; Wadood A
Bioorg Chem; 2018 Aug; 78():411-417. PubMed ID: 29689419
[TBL] [Abstract][Full Text] [Related]
16. Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.
Yang YS; Su MM; Zhang XP; Liu QX; He ZX; Xu C; Zhu HL
Bioorg Med Chem Lett; 2018 Oct; 28(19):3182-3186. PubMed ID: 30170940
[TBL] [Abstract][Full Text] [Related]
17. Biological activity of 3-formylchromones and related compounds.
Kawase M; Tanaka T; Kan H; Tani S; Nakashima H; Sakagami H
In Vivo; 2007; 21(5):829-34. PubMed ID: 18019419
[TBL] [Abstract][Full Text] [Related]
18. In-silico Designing, ADMET Analysis, Synthesis and Biological Evaluation of Novel Derivatives of Diosmin Against Urease Protein and Helicobacter pylori Bacterium.
Kataria R; Khatkar A
Curr Top Med Chem; 2019; 19(29):2658-2675. PubMed ID: 31724503
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, molecular docking and biological evaluation of Schiff base transition metal complexes as potential urease inhibitors.
Chen W; Li Y; Cui Y; Zhang X; Zhu HL; Zeng Q
Eur J Med Chem; 2010 Oct; 45(10):4473-8. PubMed ID: 20691510
[TBL] [Abstract][Full Text] [Related]
20. Competitive inhibitors of Helicobacter pylori type II dehydroquinase: synthesis, biological evaluation, and NMR studies.
Sánchez-Sixto C; Prazeres VF; Castedo L; Suh SW; Lamb H; Hawkins AR; Cañada FJ; Jiménez-Barbero J; González-Bello C
ChemMedChem; 2008 May; 3(5):756-70. PubMed ID: 18200648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
